{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:24:09Z","timestamp":1790742249560,"version":"4.1.0"},"reference-count":58,"publisher":"Impact Journals, LLC","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,7,26]]},"DOI":"10.18632\/oncotarget.10273","type":"journal-article","created":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T16:59:56Z","timestamp":1466787596000},"page":"47663-47673","source":"Crossref","is-referenced-by-count":6,"title":["The modulation of Dicer regulates tumor immunogenicity in melanoma"],"prefix":"10.18632","volume":"7","author":[{"given":"Nicholas C.","family":"Hoffend","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Medicine, Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Magner","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Medicine, Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York, USA"},{"name":"Department of Microbiology and Immunology, School of Medicine and Biomedical Sciences, State University of New York, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B.","family":"Tomasi","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Medicine, Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York, USA"},{"name":"Department of Medicine, State University of New York, Buffalo, New York, USA"},{"name":"Department of Microbiology and Immunology, School of Medicine and Biomedical Sciences, State University of New York, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,6,23]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-immunol-032713-120136","article-title":"Adoptive immunotherapy for cancer or viruses","volume":"32","author":"June","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"2","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1038\/cti.2013.5","article-title":"The delicate balance of melanoma immunotherapy","volume":"2","author":"Ariyan","year":"2013","journal-title":"Clin Transl Immunology"},{"key":"3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coi.2014.01.004","article-title":"New insights into cancer immunoediting and its three component phases--elimination equilibrium and escape","volume":"27","author":"Smyth","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1158\/2326-6066.CIR-13-0097","article-title":"Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapy","volume":"2","author":"Luiten","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"5","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/cncr.24909","article-title":"Tumor progression by immune evasion in melanoma: role of the programmed cell death-1\/programmed cell death-1 ligand 1 interaction","volume":"116","author":"Kashani-Sabet","year":"2010","journal-title":"Cancer"},{"key":"6","first-page":"8647","article-title":"Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway","volume":"61","author":"Ferrone","year":"2001","journal-title":"Cancer Res"},{"key":"7","first-page":"49","article-title":"Immune escape mechanisms in malignant melanoma","volume":"3","author":"Dummer","year":"1999","journal-title":"Int J Mol Med"},{"key":"8","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1126\/science.274.5291.1363","article-title":"Melanoma cell expression of Fas(Apo-1\/CD95) ligand: implications for tumor immune escape","volume":"274","author":"Tschopp","year":"1996","journal-title":"Science"},{"key":"9","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1200\/JCO.2014.56.2736","article-title":"Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma","volume":"33","author":"Wolchok","year":"2015","journal-title":"J Clin Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ctrv.2014.06.012","article-title":"Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma","volume":"40","author":"Balch","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Kim","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nature09092","article-title":"A dicer-independent miRNA biogenesis pathway that requires Ago catalysis","volume":"465","author":"Hannon","year":"2010","journal-title":"Nature"},{"key":"14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ng1253","article-title":"Dicer is essential for mouse development","volume":"35","author":"Hannon","year":"2003","journal-title":"Nat Genet"},{"key":"15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3109\/08820139.2013.863557","article-title":"Dicer in immune cell development and function","volume":"43","author":"Tomasi","year":"2014","journal-title":"Immunol Invest"},{"key":"16","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrc3802","article-title":"DICER1: mutations microRNAs and mechanisms","volume":"14","author":"Duchaine","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-014-1285-z","article-title":"Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations","volume":"128","author":"Esbenshade","year":"2014","journal-title":"Acta Neuropathol"},{"key":"18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1126\/science.1174334","article-title":"DICER1 mutations in familial pleuropulmonary blastoma","volume":"325","author":"Messinger","year":"2009","journal-title":"Science"},{"key":"19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ng2003","article-title":"Impaired microRNA processing enhances cellular transformation and tumorigenesis","volume":"39","author":"Jacks","year":"2007","journal-title":"Nat Genet"},{"key":"20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/era.12.150","article-title":"Altered expression of the miRNA processing endoribonuclease Dicer has prognostic significance in human cancers","volume":"13","author":"Frampton","year":"2013","journal-title":"Expert Rev Anticancer Ther"},{"key":"21","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/onc.2012.239","article-title":"Sox4-mediated Dicer expression is critical for suppression of melanoma cell invasion","volume":"32","author":"Li","year":"2013","journal-title":"Oncogene"},{"key":"22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1684\/ejd.2011.1210","article-title":"Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas benign melanocytic nevi and dysplastic melanocytic nevi","volume":"21","author":"Bechara","year":"2011","journal-title":"Eur J Dermatol"},{"key":"23","doi-asserted-by":"crossref","first-page":"e20494","DOI":"10.1371\/journal.pone.0020494","article-title":"Up-regulated Dicer expression in patients with cutaneous melanoma","volume":"6","author":"Dadras","year":"2011","journal-title":"PLoS One"},{"key":"24","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.molimm.2007.10.035","article-title":"MicroRNA targets in immune genes and the Dicer\/Argonaute and ARE machinery components","volume":"45","author":"Tomasi","year":"2008","journal-title":"Mol Immunol"},{"key":"25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.12367","article-title":"Immuno-miRs: critical regulators of T-cell development function and ageing","volume":"144","author":"Kluiver","year":"2015","journal-title":"Immunology"},{"key":"26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/cmi.2012.62","article-title":"The role of microRNAs in B-cell development and function","volume":"10","author":"Wu","year":"2013","journal-title":"Cell Mol Immunol"},{"key":"27","doi-asserted-by":"crossref","first-page":"10746","DOI":"10.1073\/pnas.0811817106","article-title":"Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1","volume":"106","author":"Okada","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"28","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1158\/0008-5472.CAN-11-1977","article-title":"Tumor suppressive microRNAs miR-34a\/c control cancer cell expression of ULBP2 a stress-induced ligand of the natural killer cell receptor NKG2D","volume":"72","author":"Paschen","year":"2012","journal-title":"Cancer Res"},{"key":"29","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ni.1642","article-title":"Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D","volume":"9","author":"Mandelboim","year":"2008","journal-title":"Nat Immunol"},{"key":"30","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1158\/0008-5472.CAN-11-2671","article-title":"MiR-10b downregulates the stress-induced cell surface molecule MICB a critical ligand for cancer cell recognition by natural killer cells","volume":"72","author":"Mandelboim","year":"2012","journal-title":"Cancer Res"},{"key":"31","doi-asserted-by":"crossref","first-page":"11571","DOI":"10.1007\/s13277-014-2462-3","article-title":"Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer","volume":"35","author":"Ye","year":"2014","journal-title":"Tumour Biol"},{"key":"32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3892\/ijo_00000678","article-title":"Downregulation of Dicer enhances tumor cell proliferation and invasion","volume":"37","author":"Kang","year":"2010","journal-title":"Int J Oncol"},{"key":"33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4049\/jimmunol.154.1.180","article-title":"Multiple defects in innate and adaptive immunologic function in NOD\/LtSz-scid mice","volume":"154","author":"Greiner","year":"1995","journal-title":"J Immunol"},{"key":"34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/imr.12132","article-title":"Exploiting the curative potential of adoptive T-cell therapy for cancer","volume":"257","author":"Rosenberg","year":"2014","journal-title":"Immunol Rev"},{"key":"35","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1172\/JCI24480","article-title":"Acquisition of full effector functionparadoxically impairs theantitumor efficacy of adoptively transferred CD8+ T cells","volume":"115","author":"Restifo","year":"2005","journal-title":"J Clin Invest"},{"key":"36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.20030590","article-title":"Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells","volume":"198","author":"Yu","year":"2003","journal-title":"J Exp Med"},{"key":"37","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1158\/0008-5472.CAN-13-2470","article-title":"Biallelic DICER1 mutations in sporadic pleuropulmonary blastoma","volume":"74","author":"Nomura","year":"2014","journal-title":"Cancer Res"},{"key":"38","first-page":"4802","article-title":"Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours","volume":"2","author":"Amatruda","year":"2014","journal-title":"Nat Commun"},{"key":"39","doi-asserted-by":"crossref","first-page":"e71969","DOI":"10.1371\/journal.pone.0071969","article-title":"Unique haploinsufficient role of the microRNA-processing molecule Dicer1 in a murine colitis-associated tumorigenesis model","volume":"8","author":"Koike","year":"2013","journal-title":"PLoS One"},{"key":"40","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/path.4196","article-title":"Biallelic DICER1 mutations occur in Wilms tumours","volume":"230","author":"Iglesias","year":"2013","journal-title":"J Pathol"},{"key":"41","first-page":"269","article-title":"Expression levels of microRNA machinery components Drosha Dicer and DGCR8 in human (AGS HepG2 and KEYSE-30) cancer cell lines","volume":"6","author":"Zargar","year":"2013","journal-title":"Int J Clin Exp Med"},{"key":"42","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/hep.26202","article-title":"Argonaute2 promotes tumor metastasis by way of up-regulating focal adhesion kinase expression in hepatocellular carcinoma","volume":"57","author":"Han","year":"2013","journal-title":"Hepatology"},{"key":"43","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1056\/NEJMoa1102903","article-title":"Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers","volume":"366","author":"Ha","year":"2012","journal-title":"N Engl J Med"},{"key":"44","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.molmed.2012.07.003","article-title":"Exploring the endocrine manifestations of DICER1 mutations","volume":"18","author":"Foulkes","year":"2012","journal-title":"Trends Mol Med"},{"key":"45","doi-asserted-by":"crossref","first-page":"e21253","DOI":"10.1371\/journal.pone.0021253","article-title":"A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis","volume":"6","author":"Hogaboam","year":"2011","journal-title":"PLoS One"},{"key":"46","doi-asserted-by":"crossref","first-page":"7904","DOI":"10.1073\/pnas.0908441107","article-title":"High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2\/AGO2","volume":"107","author":"Shaughnessy","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"47","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1523\/JNEUROSCI.0828-08.2008","article-title":"Dicer inactivation leads to progressive functional and structural degeneration of the mouse retina","volume":"28","author":"Strettoi","year":"2008","journal-title":"J Neurosci"},{"key":"48","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1073\/pnas.0710228105","article-title":"Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure","volume":"105","author":"Wang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"49","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jneuroim.2016.01.009","article-title":"Dicer and microRNA expression in multiple sclerosis and response to interferon therapy","volume":"292","author":"Tomasi","year":"2016","journal-title":"J Neuroimmunol"},{"key":"50","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.molimm.2008.11.012","article-title":"Dicer is regulated by cellular stresses and interferons","volume":"46","author":"Tomasi","year":"2009","journal-title":"Mol Immunol"},{"key":"51","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1479-5876-5-64","article-title":"An epigenetic vaccine model active in the prevention and treatment of melanoma","volume":"5","author":"Tomasi","year":"2007","journal-title":"J Transl Med"},{"key":"52","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1158\/0008-5472.CAN-13-0890","article-title":"An intact immune system is required for the anticancer activities of histone deacetylase inhibitors","volume":"73","author":"Johnstone","year":"2013","journal-title":"Cancer Res"},{"key":"53","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1177\/1352458514560923","article-title":"Decreased Dicer expression is linked to increased expression of co-stimulatory molecule CD80 on B cells in multiple sclerosis","volume":"21","author":"Balashov","year":"2015","journal-title":"Mult Scler"},{"key":"54","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10549-012-2169-3","article-title":"Loss of Dicer expression is associated with breast cancer progression and recurrence","volume":"135","author":"Green","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"55","first-page":"340","article-title":"Argonaute 2 is up-regulated in tissues of urothelial carcinoma of bladder","volume":"7","author":"Zheng","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"56","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10238-013-0243-8","article-title":"An essential microRNA maturing microprocessor complex component DGCR8 is up-regulated in colorectal carcinomas","volume":"14","author":"Kim","year":"2014","journal-title":"Clin Exp Med"},{"key":"57","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/path.2898","article-title":"Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles","volume":"224","author":"Coleman","year":"2011","journal-title":"J Pathol"},{"key":"58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2407-10-38","article-title":"Argonaute proteins: potential biomarkers for human colon cancer","volume":"10","author":"Li","year":"2010","journal-title":"BMC Cancer"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:42:38Z","timestamp":1692405758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,23]]},"references-count":58,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2016,7,26]]}},"alternative-id":["10273","27356752"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.10273","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,23]]}}}